A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes

Phase 2

Completed

• Conditions: Diabetes Mellitus, Type 1

• Registration Number: NCT00146484
• Lead Sponsor: Children's Hospital of Eastern Ontario

Brief Summary

The optimal insulin regimen for children and adolescents with newly diagnosed type 1 diabetes remains unknown. The purpose of this study is to determine whether a split evening injection regimen (insulin injections before breakfast, supper and bedtime) leads to better glucose control and quality of life than twice daily insulin in children and adolescents with new onset diabetes.

Detailed Description

The optimal insulin regimen for children and adolescents with newly diagnosed type 1 diabetes remains unknown. No published studies have examined the effectiveness of a split evening (three times daily) injection regimen in this group of patients. Indeed, because the first few years of diabetes management are the easiest (due to a "honeymoon" period characterised by residual insulin secretion), the potential for any benefit from more intensive management (i.e., three daily injections) may be small during this period. In addition, the intensity of the initial insulin regimen may be an important determinant of quality of life, family functioning, and subsequent compliance with diabetes regimens. A randomized controlled trial has been designed to test the hypothesis that a split evening injection regimen leads to better glycemic control and quality of life than twice daily insulin in children and adolescents with new onset diabetes.

Study Timeline

• Study Start: 1996-04
• Study Completion: 2001-01
• Status Verified: 2005-09
• Study First Submitted: 2005-09-06
• Study First Submitted QC: 2005-09-06
• Last Update Submitted: 2005-09-06
• Study First Posted: 2005-09-07
• Last Update Posted: 2005-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• New onset type 1 diabetes
• Less than 48 hours since first insulin injection
• Child and/or parent able to read and write English
• Family intends to continue treatment at our institution for the next two years
• Informed consent from adolescents greater than 16 years of age, or if less than 16 years, informed consent from the parent/guardian with assent from the child.

Exclusion Criteria

• Chronic medical conditions other than treated hypothyroidism or mild asthma
• Concerns of the diabetes team regarding future treatment adherence making twice daily insulin preferable to the split evening injection regimen (e.g., cognitive impairment, severe family dysfunction).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
* Hemoglobin A1c over the first 24 months of diabetes

Secondary Outcome Measures

Name	Time	Method
* Frequency of hypoglycemia (mild and severe) over the first 24 months of diabetes
* Frequency of morning hyperglycemia over the first 24 months of diabetes
* Residual c-peptide at two years post diagnosis (stimulated c-peptide post Sustacal challenge)
* Family Functioning (Family Environment Scale)over the first 24 months of diabetes
* Diabetes Quality of Life (DQOLY) over the first 24 months of diabetes

Trial Locations

Locations (1)

Children's Hospital of Eastern Ontario; 🇨🇦 Ottawa, Ontario, Canada